Cargando…
TP53 and PTEN as driver mutations in Zenker's carcinoma—a clinical presentation
Zenker carcinoma is still being treated empirically because of the lack of evidence‐ based guidelines. We report for the first time about the genetic examination of this rare entity. The revealed mutations show genetic similarities with HPV(‐)HNSCC which suggests that well‐known therapeutic strategi...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752333/ https://www.ncbi.nlm.nih.gov/pubmed/33363824 http://dx.doi.org/10.1002/ccr3.3169 |